Replies to post #2548 on Cytori Therapeutics, Inc. (CYTX)

[tilator]

Cytori Provides Update on US Manufacturing and EU Approval Plans for ATI-0918, Liposomal Doxorubicin

This is important, because there is not any generic competition.

It's way more important than any other Cytori product.